Precision radiation aims to spare kidneys in cancer fight
NCT ID NCT07402109
First seen Feb 11, 2026 · Last updated Jun 23, 2026 · Updated 24 times
Summary
This study tests a new way to deliver radiotherapy for kidney cancer that uses advanced imaging to target the tumor more precisely. The goal is to reduce radiation damage to healthy kidney tissue. About 40 adults with non-spreading kidney cancer will receive this treatment. Researchers will measure how much healthy kidney is spared and whether the tumor is still fully covered.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA (RCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus MC
RECRUITINGRotterdam, South Holland, 3000CA, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy
What this could lead to
If successful, this approach could allow more precise, kidney-sparing radiotherapy for kidney cancer patients, reducing side effects.
What could go wrong
This is a small, early-phase study with only 40 participants. The technique may not improve outcomes or could cause additional radiation exposure from extra imaging.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.